AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16(INK4A) mRNA with prognostic significance

Hendrik J. M. de Jonge, Eveline S. J. M. de Bont, Peter J. M. Valk, Jan Jacob Schuringa, Marcel Kies, Carolien M. Woolthuis, Ruud Delwel, Nic J. G. M. Veeger, Edo Vellenga, Bob Lowenberg, Gerwin Huls*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

46 Citations (Scopus)

Abstract

Acute myeloid leukemia (AML) has a different clinical and biologic behavior in patients at older age. To gain further insight into the molecular differences, we examined a cohort of 525 adults to compare gene expression profiles of the one-third of youngest cases (n = 175; median age 31 years) with the one-third of oldest cases (n = 175; median age 59 years). This analysis revealed that 477 probe sets were up-regulated and 492 probe sets were down-regulated with increasing age at the significance level of P

Original languageEnglish
Pages (from-to)2869-2877
Number of pages9
JournalBlood
Volume114
Issue number14
DOIs
Publication statusPublished - 1-Oct-2009

Keywords

  • ACUTE-MYELOID-LEUKEMIA
  • COLONY-STIMULATING FACTOR
  • HEMATOPOIETIC STEM-CELLS
  • TUMOR-SUPPRESSOR LOCUS
  • MYELODYSPLASTIC SYNDROMES
  • CELLULAR SENESCENCE
  • ELDERLY-PATIENTS
  • PATIENT AGE
  • BMI-1
  • PROTEINS

Fingerprint

Dive into the research topics of 'AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16(INK4A) mRNA with prognostic significance'. Together they form a unique fingerprint.

Cite this